As Novartis builds an empire of radiopharmaceuticals, the Swiss pharma has ramped up legal actions against its competitors. | As Novartis builds an empire of radiopharmaceuticals, the Swiss pharma has ...

Exacerbations of the chronic and progressive inflammatory disease bronchiectasis can impact quality of life. Treatment, based ...

The company’s MI Cancer Seek is approved as a companion diagnostic for multiple cancer therapies, including MSD’s Keytruda, ...

In 2023, Aditum’s weight loss biotech Versanis Bio sold to Eli Lilly for up to $1.92 billion in upfront payments and ...

The whole-exome sequencing and whole-transcriptome sequencing-based test is approved for molecular profiling of solid tumors.

A new guideline advises most patients to continue GLP-1 drugs before surgery. The FDA warns against California-made ...

Demis Hassabis, joint winner of the Nobel Prize in Chemistry 2024, shared insights on AI at the FT Pharma and Biotech Summit.

UK cost-effectiveness agency NICE has said that Eli Lilly’s Emgality can be made ... the first drug in the class to be approved in Europe – Novartis’ Aimovig (erenumab) – has fallen ...

Prediabetes market size is estimated to reach USD 360.6 million by the end of 2032. The industry growth is driven by the ...

Patients with moderate to severe HS experienced sustained symptomatic and quality-of-life improvements with the monoclonal ...

Awareness among Younger Generation Higher about Benefits of Timely Sarcopenia Treatment InterventionRockville, MD, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The world population has crossed 8 billion, with a ...